| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48,2 M € | +4.5% | 46,2 M € | -10.8% | 51,7 M € | +2.8% | 50,3 M € | +17.1% | 43,0 M € | +50.8% | 28,5 M € | +38.7% | 20,5 M € | +74.8% | 11,7 M € | -8.0% | 12,8 M € | -32.2% | 18,8 M € | -26.6% | 25,7 M € | -27.0% | 35,1 M € | +142.6% | 14,5 M € | |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | 3,3 M € | |||||||||||||
| EBITDA | -17,5 M € | +22.6% | -22,6 M € | +29.6% | -32,1 M € | +19.2% | -39,7 M € | +28.7% | -55,6 M € | -48.9% | -37,4 M € | -10.5% | -33,8 M € | +22.5% | -43,6 M € | -34.5% | -32,4 M € | -195.1% | -11,0 M € | -236.1% | -3,3 M € | -341.6% | 1,4 M € | +3265.2% | 40,2 k € | |
| Operating profit | -22,0 M € | +24.9% | -29,3 M € | +46.1% | -54,3 M € | +4.8% | -57,0 M € | +21.6% | -72,8 M € | -40.4% | -51,8 M € | -5.4% | -49,2 M € | +16.8% | -59,1 M € | -23.9% | -47,7 M € | -134.1% | -20,4 M € | -213.5% | -6,5 M € | -710.6% | -801,4 k € | -863.8% | -83,2 k € | |
| Profit/loss | -22,9 M € | +25.5% | -30,8 M € | +47.0% | -58,0 M € | -2.2% | -56,8 M € | +22.0% | -72,8 M € | -35.1% | -53,9 M € | -5.2% | -51,2 M € | +15.0% | -60,3 M € | -24.7% | -48,3 M € | -134.8% | -20,6 M € | -197.3% | -6,9 M € | -495.4% | -1,2 M € | -304.2% | -287,5 k € | |
| Equity | 37,2 M € | -27.1% | 51,0 M € | +509.7% | -12,5 M € | -127.2% | 45,8 M € | +895.6% | -5,8 M € | +94.9% | -112,1 M € | -92.5% | -58,2 M € | -721.3% | -7,1 M € | -113.5% | 52,5 M € | -48.0% | 101,0 M € | +687.3% | 12,8 M € | +4281.0% | -306,9 k € | -154.7% | 560,9 k € | |
| Total assets | 61,8 M € | -12.0% | 70,2 M € | -26.7% | 95,7 M € | -0.2% | 95,9 M € | -30.2% | 137,3 M € | -1.4% | 139,2 M € | -7.4% | 150,4 M € | +4.4% | 144,1 M € | -2.1% | 147,2 M € | -0.3% | 147,6 M € | +264.3% | 40,5 M € | -44.6% | 73,2 M € | +215.1% | 23,2 M € | |
| Cash | 6,1 M € | -25.2% | 8,1 M € | -70.1% | 27,0 M € | +108.2% | 13,0 M € | -66.7% | 39,0 M € | +235.9% | 11,6 M € | -43.3% | 20,5 M € | +41.4% | 14,5 M € | -35.7% | 22,5 M € | +133.9% | 9,6 M € | -53.7% | 20,8 M € | +68.4% | 12,4 M € | +511.8% | 2,0 M € | |
| Debts | 23,5 M € | +29.0% | 18,2 M € | -82.7% | 105,4 M € | +116.8% | 48,6 M € | -65.3% | 140,1 M € | -43.2% | 246,8 M € | +20.9% | 204,0 M € | +37.9% | 148,0 M € | +66.1% | 89,1 M € | +143.4% | 36,6 M € | +41.6% | 25,8 M € | -64.0% | 71,9 M € | +230.4% | 21,8 M € | |
| Staff | 205,6 | 227,8 | 278,5 | 312,5 | 308,7 | 231,6 | 215,8 | 194,3 | 173,8 | 134,4 | 102,3 | 73,1 | 14,4 | |||||||||||||
Public limited company · Mechelen · incorporated on 02/07/2010 · 205,6 ETP
Public limited company loss-making in the latest fiscal year. Cash position declining (-25.2%).
Solid counterparty for a standard engagement.
BIOCARTIS is a Public limited company incorporated in 2010. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Mechelen. It employs on average 205,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette